title: Contrast-enhanced ultrasonography in diagnosis of benign and malignant breast lesions.
abstract: OBJECTIVE
  This study aims to investigate the value of real-time contrast-enhanced ultrasonography (US) in differentiating benign and malignant breast lumps.
  
  
  METHODS
  Patients with breast lesions were observed. The enhancement form, intensity, and time-intensity curve were classified, and the characteristics of all the lesions were analyzed.
  
  
  RESULTS
  Inhomogeneous partial enhancement and entire enhancement were exhibited in most of the malignant lesions. High enhancements were observed in malignant lesions, whereas lower enhancement and no enhancement were exhibited in the benign tumors. The peak value and regression time were significantly different between the two groups.
  
  
  CONCLUSIONS
  There's a significant difference regarding the results of real-time contrast-enhanced ultrasound between the benign tumor and malignant tumor which would help to improve the diagnostic accuracy of breast neoplasms.
authors.forename: X Y
authors.initials: XY
authors.lastname: Wang
authors.forename: L K
authors.initials: LK
authors.lastname: Kang
authors.forename: C Y
authors.initials: CY
authors.lastname: Lan
mesh_terms: D018262:Adenocarcinoma, Clear Cell / Q000000981:diagnostic imaging / Q000473:pathology; D002288:Adenocarcinoma, Mucinous / Q000000981:diagnostic imaging / Q000473:pathology; D000328:Adult; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000000981:diagnostic imaging* / Q000473:pathology; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000000981:diagnostic imaging* / Q000473:pathology; D003287:Contrast Media; D005260:Female; D018226:Fibroadenoma / Q000000981:diagnostic imaging* / Q000473:pathology; D005348:Fibrocystic Breast Disease / Q000000981:diagnostic imaging* / Q000473:pathology; D006801:Humans; D008875:Middle Aged; D018300:Papilloma, Intraductal / Q000000981:diagnostic imaging* / Q000473:pathology; D010743:Phospholipids; D003557:Phyllodes Tumor / Q000000981:diagnostic imaging* / Q000473:pathology; D013459:Sulfur Hexafluoride; D018615:Ultrasonography, Doppler, Color / Q000379:methods*; D016217:Ultrasonography, Mammary / Q000379:methods*
chemical_list: D003287:Contrast Media; D010743:Phospholipids; C420843:contrast agent BR1; D013459:Sulfur Hexafluoride